Back to 
STATE STREET CORP
STATE STREET CORP
STLNShowing 8 of 11 quarters
Position history for STATE STREET CORP's holdings in Starling Oncology, Inc.
STATE STREET CORP holds 1.6M shares of STLN (Starling Oncology, Inc.), worth $8.4M as of 2026-Q2. The position was increased (+6.3% shares). STLN represents 0.0% of STATE STREET CORP's portfolio.
Current Value
$8.4M
Current Shares
1.6M
Total Value Change
+$8.4M
Total Shares Change
+1.5M
Quarter-by-Quarter History
Other major holders of STLN: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC